Search Results - "Ni, Yuchao"

G9a in Cancer: Mechanisms, Therapeutic Advancements, and Clinical Implications.

Authors: Ni, Yuchao Shi, Mingchen Liu, Liangliang et al.

Source: Cancers. Jun2024, Vol. 16 Issue 12, p2175. 17p.

Deciphering the Transcription Factor Landscape in Prostate Cancer Progression: A Novel Approach to Understand NE Transdifferentiation (Adv. Sci. 20/2025).

Authors: Wang, Yu Xue, Hui Zhu, Xiaohui et al.

Source: Advanced Science. 5/29/2025, Vol. 12 Issue 20, p1-1. 1p.

Exosomal TUBB3 mRNA expression of metastatic castration‐resistant prostate cancer patients: Association with patient outcome under abiraterone.

Authors: Zhu, Sha Ni, Yuchao Sun, Guangxi et al.

Source: Cancer Medicine. Sep2021, Vol. 10 Issue 18, p6282-6290. 9p.

Patients with ASPSCR1-TFE3 fusion achieve better response to ICI based combination therapy among TFE3-rearranged renal cell carcinoma.

Authors: Zhao, Junjie Tang, Yanfeng Hu, Xu et al.

Source: Molecular Cancer. 6/26/2024, Vol. 23 Issue 1, p1-8. 8p.

Corticosteroid switch from prednisone to dexamethasone in metastatic castration-resistant prostate cancer patients with biochemical progression on abiraterone acetate plus prednisone.

Authors: Yang, Zhenyu Ni, Yuchao Zhao, Diwei et al.

Source: BMC Cancer. 8/13/2021, Vol. 21 Issue 1, p1-9. 9p.

Chronological Liquid Biopsy Reveals the Impact of Platinum-Based Chemotherapy on a Prostate Cancer Patient's CDK12 Mutation: A Case Report.

Authors: Zhu, Sha Bao, Yige Zheng, Linmao et al.

Source: OncoTargets & Therapy. Sep2022, Vol. 15, p947-952. 6p.

The efficacy and safety of radical prostatectomy and radiotherapy in high-risk prostate cancer: a systematic review and meta-analysis.

Authors: Wang, Zhipeng Ni, Yuchao Chen, Junru et al.

Source: World Journal of Surgical Oncology. 2/24/2020, Vol. 18 Issue 1, p1-13. 13p.

Homologous recombination deficiency (HRD) score in aggressive prostatic adenocarcinoma with or without intraductal carcinoma of the prostate (IDC-P).

Authors: Zhu, Sha Zhao, Jinge Nie, Ling et al.

Source: BMC Medicine. 7/22/2022, Vol. 20 Issue 1, p1-13. 13p.

Circulating tumour DNA reveals genetic traits of patients with intraductal carcinoma of the prostate.

Authors: Zhao, Jinge Sun, Guangxi Zhu, Sha et al.

Source: BJU International. Mar2022, Vol. 129 Issue 3, p345-355. 11p.

This result is not displayed to guests.
Login for full access.

Integrated multi-omics analyses reveal that BCAM is associated with epigenetic modification and tumor microenvironment subtypes of clear cell renal cell carcinoma.

Authors: Zhao, Junjie Liang, Jiayu Yang, Yang et al.

Source: Clinical Epigenetics. 8/8/2022, Vol. 14 Issue 1, p1-15. 15p.

The Impact of Renal Impairment on Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With Tyrosine Kinase Inhibitors.

Authors: Zhang, Haoran Zhang, Xingming Zhu, Xudong et al.

Source: Cancer control: journal of the Moffitt Cancer Center 12/3/2020.

Journal Info: Publisher: Sage Publications Inc. ISSN: 1073-2748

Echocardiographic left ventricular hypertrophy and geometry in Chinese chronic hemodialysis patients: the prevalence and determinants.

Authors: Zhao X Zhu L Jin W et al.

Source: BMC cardiovascular disorders [BMC Cardiovasc Disord] 2022 Feb 16; Vol. 22 (1), pp. 55. Date of Electronic Publication: 2022 Feb 16.

Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100968539 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2261 (Electronic) Linking ISSN: 14712261 NLM ISO Abbreviation: BMC Cardiovasc Disord Subsets: MEDLINE